Showing results (3821-3830 of 5,227) with videos related to
Sort By:
Pageof 523
Antiviral Research|March 31, 2024
Early application of IFNγ mediated the persistence of HBV in an HBV mouse modelJingjiao Song, Xiliang Sun, Yun Zhou, et al.Antiviral Research|March 6, 2024
A virus-like particle candidate vaccine based on CRISPR/Cas9 gene editing technology elicits broad-spectrum protection against SARS-CoV-2Weiqi Wang, Shen Wang, Xianyong Meng, et al.Antiviral Research|July 6, 2024
Characterization of clinical envelopes with lack of sensitivity to the HIV-1 inhibitors temsavir and ibalizumabMargaret Gartland, Eugene Stewart, Nannan Zhou, et al.Antiviral Research|July 7, 2024
Prevention of post COVID-19 condition by early treatment with ensitrelvir in the phase 3 SCORPIO-SR trialHiroshi Yotsuyanagi, Norio Ohmagari, Yohei Doi, et al.Antiviral Research|July 3, 2024
The sensitivity of HIV-1 gp120 polymorphs to inhibition by temsavir correlates to temsavir binding on-rateDavid Wensel, Margaret Gartland, Jagadish Beloor, et al.Antiviral Research|March 28, 2024
Nanomolar anti-SARS-CoV-2 Omicron activity of the host-directed TMPRSS2 inhibitor N-0385 and synergistic action with direct-acting antiviralsJimena Pérez-Vargas, Gabriel Lemieux, Connor A H Thompson, et al.Antiviral Research|April 12, 2024
Inhalation of 2, 4-di-tert-butylphenol-Loaded micelles suppresses respiratory syncytial virus infection in miceMingyang Guo, Jianqing Peng, Pengcheng Guo, et al.Antiviral Research|January 20, 2024
Molecular mechanism of rhinovirus escape from the Pyrazolo[3,4-d]pyrimidine capsid-binding inhibitor OBR-5-340 via mutations distant from the binding pocket: Derivatives that brake resistanceMartina Richter, Kristin Döring, Dieter Blaas, et al.Antiviral Research|September 5, 2024
Dynamic features of virus protein 1 and substitutions in the 3-phenyl ring determine the potency and broad-spectrum activity of capsid-binding pyrazolo[3,4-d]pyrimidines against rhinovirusesMartina Richter, Maria Khrenova, Elena Kazakova, et al.Antiviral Research|August 24, 2024
Coronavirus nucleocapsid-based vaccine provides partial protection against hetero-species coronavirus in murine modelsPureum Lee, Jihee Kim, Hanseul Oh, et al.Pageof 523